Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)
NCT ID: NCT02246348
Last Updated: 2016-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2014-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The TPD performance in detecting PAH in SSc patients will be assessed in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)
NCT02278445
Measuring Blood Pressure in the Lung Circulation With Sonar Technology (Echo-Doppler)
NCT01357746
Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients
NCT01913457
Evaluation of Lung Doppler Signals in Pulmonary Hypertension
NCT01839786
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
NCT01800292
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Doppler ultrasound
Doppler ultrasound
Recording Doppler ultrasound noninvasively from the right chest wall
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doppler ultrasound
Recording Doppler ultrasound noninvasively from the right chest wall
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or female, ≥ 18 years of age
3. Diagnosis of SSc according to 2013 ACR/EULAR SSc Classification Criteria (van den Hoogen 2013): Score ≥ 9.
4. Patients with RHC data available from measurement within 3 weeks prior to TPD assessment
5. No change in or initiation of PAH specific therapy between the last RHC and TPD
Exclusion Criteria
2. PCWP or LVEDP \> 15 mmHg
3. Any PH etiology outside Group 1 (Dana Point, 2008)
4. Pregnant women
5. Patients having severe chest wall deformity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Echosense Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexsandra Balbir, Dr
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reumatology department, Rambam medical center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DOP22_2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.